Patent directory · USPTO A61K / A61P
Patents matching “progression”
17 pharma patents match "progression" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 17 pharmaceutical patents matching "progression" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2025233516
MÉTHODE D'AUGMENTATION DU TEMPS JUSQU'À LA DEUXIÈME PROGRESSION ET DU TEMPS JUSQU'À LA PREMIÈRE CHIMIOTHÉRAPIE SUIVANTE
granted -
US 11180562
Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies
granted -
US 11052089
Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype
granted -
US 9315534
Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents
granted -
US 7053263
Mouse models of human prostate cancer progression
granted -
US 6956145
Mice models of human prostate cancer progression
expired -
US 6949690
Methods of assessing the effect of a gene of interest on human prostate cancer progression
expired -
US 6815574
Methods of simulating human prostate cancer progression
expired -
US 6790615
Methods and compositions for regulating cell cycle progression
expired -
US 6689561
Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
expired -
US 6673559
Met proto-oncogene and a method for predicting breast cancer progression
expired -
US 6600030
Delayed progression to aids by a missense allele of the CCR2 gene
expired -
US 6365797
Mice models of human prostate cancer progression
expired -
US 6245752
Compositions and methods for tolerization in immune complex-mediated disease progression
expired -
US 6224866
Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
expired -
US 6183961
Methods and compositions for regulating cell cycle progression
expired -
US 6107540
Mice models of human prostate cancer progression
expired